Mira Pharmaceuticals, Inc. (MIRA) — 10-Q Filings
All 10-Q filings from Mira Pharmaceuticals, Inc.. Browse 6 Quarterly Report reports with AI-powered summaries and risk analysis.
10-Q Filings (6)
-
MIRA Pharma's Q3 Loss Widens on Deemed Dividend, Acquires SKNY
— Nov 13, 2025 Risk: high
MIRA Pharmaceuticals, Inc. reported no revenue for the three and nine months ended September 30, 2025, consistent with its clinical-stage status. The company's -
Mira Pharmaceuticals Files 10-Q for Q2 2025
— Aug 14, 2025 Risk: medium
Mira Pharmaceuticals, Inc. filed its 10-Q for the period ending June 30, 2025. The company, formerly Mira1a Therapeutics, Inc., is based in Miami, Florida, and -
Mira Pharmaceuticals Files Q1 2025 10-Q
— May 14, 2025 Risk: low
Mira Pharmaceuticals, Inc. filed its quarterly report for the period ending March 31, 2025. The company, formerly known as Mira1a Therapeutics, Inc., is based i -
Mira Pharmaceuticals Files Q3 2024 10-Q
— Nov 12, 2024 Risk: medium
Mira Pharmaceuticals, Inc. filed a 10-Q for the period ending September 30, 2024. The filing covers financial information and business operations for the third -
Mira Pharmaceuticals Files Q2 2024 10-Q
— Aug 13, 2024 Risk: medium
Mira Pharmaceuticals, Inc. filed its 10-Q for the period ending June 30, 2024. The company, formerly known as Mira1a Therapeutics, Inc., is incorporated in Flor -
Mira Pharmaceuticals Files 10-Q for Period Ending March 31, 2024
— May 13, 2024 Risk: low
MIRA PHARMACEUTICALS, INC. (MIRA) filed a Quarterly Report (10-Q) with the SEC on May 13, 2024. Mira Pharmaceuticals, Inc. filed a 10-Q report for the quarterly
Popular Companies
AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX